-
2m 39sPart 1 | Session 2 Real-World Data for CV and Renal Outcomes in Diabetic Kidney Disease
-
2m 52s
-
10m 48s
-
3m 10sPart 1 | Session 5 Albuminuria, eGFR Dip and Disease Severity & Empagliflozin
-
5m 27s
-
4m 16sPart 1 | Session 7 Treating Obesity in 2025 and Beyond
-
5m 36sPart 2 | Session 1 Highlights with Dr Johannes Stegbauer
-
1m 45sPart 2 | Session 2 Highlights with Dr Kywe Kywe Soe
ERA 2025 - Dr Ellen Linnea Freese Ballegaard (Copenhagen University Hospital, Copenhagen, DK) joins us to discuss a study investigating guideline-based management of CKD and evaluate the associated risk of cardio-renal outcomes. 315,636 patients were identified from nationwide Danish health care registers between 2011 and 2022 and enrolled in the study. The primary outcome measure was a composite of all-cause mortality, heart failure, cardiovascular disease and progression of kidney disease.
Interview Questions:
- To what extent did the patients receive care that adhered to contemporary guidelines for CKD management?
- What are the challenges and opportunities in implementing guideline-based management of CKD?
- What gaps in CKD management did the study highlight, and how can these gaps inform national public health priorities?
- What specific treatments were most predictive of poor outcomes?
- How should these findings impact clinical practice?
Recorded on-site at ERA in Vienna, 2025.
Editors: Jordan Rance, Yazmin Sadik
Videographers: David Ben-Harosh, Tom Green
Support: This is an independent interview produced by Radcliffe CVRM.
Keep up-to-date with the late-breaking presentations from the European Renal Association's 62nd congress, taking place from 4th to 7th June 2025 in Vienna. With Expert Interviews focusing on the applicability of the latest data and Highlights summarising the key take-aways, our video collection has you covered.
Comments